Reporting owner · CIK 0001959229

Rahmer Peter

Visual SEC Form 4 history across 1 companies, 9 transactions and 4 filings.

SRSee remarksRelay Therapeutics, Inc.
Open-market mix
Latest filingAug 28, 2026, 08:43 PM
Filings4Form 4 records
Buying$00 purchases
Selling$640.6K7 sales
Net value−$640.6KBuys minus sells
Companies12 securities
Most recentAug 26, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-106Jan 251Aug 26

Net value flow

Buys minus sells

Jan 25
−$550.3K
Aug 26
−$90.3K

Transaction texture

Ownership and ticket size

Average P/S size$91.5K
Median P/S size$90.3K
Direct9
Indirect0
Aug 26, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern4Derivative Transactionfiling-context1Direct Ownershipfiling-context9Large Holdings Increaseholdings2Repeat Sellerpattern510b5-1 Detectedfiling-context4

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Relay Therapeutics, Inc. on Aug 26, 2026 valued at $90,295.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Relay Therapeutics, Inc. on Aug 26, 2026 valued at $90,295.

Review SEC filing

Associated companies

Visual map of known reporting history

RLAYRelay Therapeutics, Inc.9 transactions · latest Aug 28, 2026, 08:43 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RLAYRahmer Peter
SR
sale10b5-14.50k-$9.02MS
Cluster Selling Direct Ownership 10b5-1 Detected
—08/2808/26
RLAYRahmer Peter
SR
sale17.2k-$7.62MS
Cluster Selling Direct Ownership Repeat Seller
—01/31/202501/30/2025
RLAYRahmer Peter
SR
sale26.5k-$12.0MS
Cluster Selling Direct Ownership Repeat Seller
—01/31/202501/29/2025
RLAYRahmer Peter
SR
grant139k$0A
Direct Ownership Large Holdings Increase
—01/31/202501/28/2025
RLAYRahmer Peter
SR
sale1.67k-$774kS
Cluster Selling Direct Ownership Repeat Seller
—01/31/202501/28/2025
RLAYRahmer Peter
SR
grant275k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/15/202501/10/2025
RLAYRahmer Peter
SR
sale10b5-116.5k-$7.37MS
Direct Ownership Repeat Seller 10b5-1 Detected
—01/07/202501/06/2025
RLAYRahmer Peter
SR
sale10b5-132.1k-$13.8MS
Direct Ownership Repeat Seller 10b5-1 Detected
—01/07/202501/03/2025
RLAYRahmer Peter
SR
sale10b5-132.1k-$13.3MS
Direct Ownership 10b5-1 Detected
—01/07/202501/02/2025

Rahmer Peter Insider Activity FAQ

SEC Form 4 context

Who is Rahmer Peter?

Rahmer Peter is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001959229.

Which companies has Rahmer Peter reported transactions for?

Relay Therapeutics, Inc.

When was Rahmer Peter's latest insider buy?

No open-market insider purchase is available for this period.

When was Rahmer Peter's latest insider sale?

sale at Relay Therapeutics, Inc. on Aug 26, 2026 valued at $90,295.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.